Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model

Onseok Lee, Jaeyoung Kim, Young Wook Choi, Minwon Lee, Gyuman Park, Chil Hwan Oh

Research output: Contribution to journalLetter

4 Citations (Scopus)

Abstract

Oregonin has been reported to act as a mediator of antibiosis, a liver-protective agent, an antioxidant, an anti-inflammatory agent, and to prevent cancer outbreaks. B16 melanoma cells were separated with trypsin-ethylenediaminetetraacetic acid, resuspended in 50 μl of phosphate-buffered saline and transplanted into the backs of 6- to 8-week-old male Balb/c nude mice through subcutaneous injection. Treatment doses of oregonin were administered three times weekly, for 30 days from the 11th day after transplantation of the melanoma cells, in each group. The study consisted of a control group, a dacarbazine group, an oregonin group and a dacarbazine + oregonin group. Measurements were taken before treatment and on the 5th, 7th, 10th and 15th days after treatment for each group. Based on survival rates after transplantation, the control group showed less than 50% survival after 20 days, while the treatment groups showed at least 50% survival up to the 41st day.

Original languageEnglish
Pages (from-to)842-844
Number of pages3
JournalExperimental Dermatology
Volume22
Issue number12
DOIs
Publication statusPublished - 2013 Dec 1

Fingerprint

Experimental Melanomas
Dacarbazine
Antibiosis
Protective Agents
Control Groups
Cell Transplantation
Subcutaneous Injections
Therapeutics
Nude Mice
Edetic Acid
Liver
Trypsin
Disease Outbreaks
Melanoma
Anti-Inflammatory Agents
Antioxidants
Transplantation
Phosphates
oregonin
Neoplasms

Keywords

  • Calipers
  • Melanoma
  • Micro-PET/CT
  • Oregonin
  • Stereo image

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology

Cite this

Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model. / Lee, Onseok; Kim, Jaeyoung; Choi, Young Wook; Lee, Minwon; Park, Gyuman; Oh, Chil Hwan.

In: Experimental Dermatology, Vol. 22, No. 12, 01.12.2013, p. 842-844.

Research output: Contribution to journalLetter

Lee, Onseok ; Kim, Jaeyoung ; Choi, Young Wook ; Lee, Minwon ; Park, Gyuman ; Oh, Chil Hwan. / Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model. In: Experimental Dermatology. 2013 ; Vol. 22, No. 12. pp. 842-844.
@article{cc4d49f40eeb448487b863aecb3923e9,
title = "Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model",
abstract = "Oregonin has been reported to act as a mediator of antibiosis, a liver-protective agent, an antioxidant, an anti-inflammatory agent, and to prevent cancer outbreaks. B16 melanoma cells were separated with trypsin-ethylenediaminetetraacetic acid, resuspended in 50 μl of phosphate-buffered saline and transplanted into the backs of 6- to 8-week-old male Balb/c nude mice through subcutaneous injection. Treatment doses of oregonin were administered three times weekly, for 30 days from the 11th day after transplantation of the melanoma cells, in each group. The study consisted of a control group, a dacarbazine group, an oregonin group and a dacarbazine + oregonin group. Measurements were taken before treatment and on the 5th, 7th, 10th and 15th days after treatment for each group. Based on survival rates after transplantation, the control group showed less than 50{\%} survival after 20 days, while the treatment groups showed at least 50{\%} survival up to the 41st day.",
keywords = "Calipers, Melanoma, Micro-PET/CT, Oregonin, Stereo image",
author = "Onseok Lee and Jaeyoung Kim and Choi, {Young Wook} and Minwon Lee and Gyuman Park and Oh, {Chil Hwan}",
year = "2013",
month = "12",
day = "1",
doi = "10.1111/exd.12277",
language = "English",
volume = "22",
pages = "842--844",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Efficacy of oregonin investigated by non-invasive evaluation in a B16 mouse melanoma model

AU - Lee, Onseok

AU - Kim, Jaeyoung

AU - Choi, Young Wook

AU - Lee, Minwon

AU - Park, Gyuman

AU - Oh, Chil Hwan

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Oregonin has been reported to act as a mediator of antibiosis, a liver-protective agent, an antioxidant, an anti-inflammatory agent, and to prevent cancer outbreaks. B16 melanoma cells were separated with trypsin-ethylenediaminetetraacetic acid, resuspended in 50 μl of phosphate-buffered saline and transplanted into the backs of 6- to 8-week-old male Balb/c nude mice through subcutaneous injection. Treatment doses of oregonin were administered three times weekly, for 30 days from the 11th day after transplantation of the melanoma cells, in each group. The study consisted of a control group, a dacarbazine group, an oregonin group and a dacarbazine + oregonin group. Measurements were taken before treatment and on the 5th, 7th, 10th and 15th days after treatment for each group. Based on survival rates after transplantation, the control group showed less than 50% survival after 20 days, while the treatment groups showed at least 50% survival up to the 41st day.

AB - Oregonin has been reported to act as a mediator of antibiosis, a liver-protective agent, an antioxidant, an anti-inflammatory agent, and to prevent cancer outbreaks. B16 melanoma cells were separated with trypsin-ethylenediaminetetraacetic acid, resuspended in 50 μl of phosphate-buffered saline and transplanted into the backs of 6- to 8-week-old male Balb/c nude mice through subcutaneous injection. Treatment doses of oregonin were administered three times weekly, for 30 days from the 11th day after transplantation of the melanoma cells, in each group. The study consisted of a control group, a dacarbazine group, an oregonin group and a dacarbazine + oregonin group. Measurements were taken before treatment and on the 5th, 7th, 10th and 15th days after treatment for each group. Based on survival rates after transplantation, the control group showed less than 50% survival after 20 days, while the treatment groups showed at least 50% survival up to the 41st day.

KW - Calipers

KW - Melanoma

KW - Micro-PET/CT

KW - Oregonin

KW - Stereo image

UR - http://www.scopus.com/inward/record.url?scp=84888356632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888356632&partnerID=8YFLogxK

U2 - 10.1111/exd.12277

DO - 10.1111/exd.12277

M3 - Letter

VL - 22

SP - 842

EP - 844

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 12

ER -